EPO is a hormone produced in the kidneys that regulates red cell production. The levels vary inversely with hematocrit. This assay is useful as an aid in distinguishing between primary and secondary Polycythemia. It also differentiates between appropriate secondary Polycythemia (High altitude, pulmonary disease, tobacco use) and inappropriate secondary Polycythemia (tumors). The assay helps to identify candidates for EPO replacement therapy (Chronic renal failure). The assay evaluates patients undergoing EPO replacement therapy who demonstrate inadequate hematopoeitic response
- No special preparation required
Strand Life Sciences Pvt Ltd is the state-of-the-art one point solution for oncology diagnostics, biomarker and translational research, laboratory services and clinical research services. Based out of Bangalore, Strand Life Sciences Pvt Ltd is an integration of Laboratory services, Research and Development and Clinical Research with a focus to on innovation, quality and accuracy for better diagnosis and prognosis of Cancer.